WST - Company ID 0000105770
The table below shows WEST PHARMACEUTICAL SERVICES INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $791.30M | $484.60M | $853.90M | $894.30M | $762.60M | $615.50M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $574.40M | $552.50M | $512.00M | $507.40M | $489.00M | $385.30M |
| Inventory | $443.90M | $377.00M | $434.70M | $414.80M | $378.40M | $321.30M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.98B |
| $1.54B |
| $1.94B |
| $1.92B |
| $1.74B |
| $1.37B |
| Property, plant & equipment | $1.73B | $1.58B | $1.41B | $1.16B | $1.06B | $943.20M |
| Goodwill | $109.90M | $106.00M | $108.50M | $107.30M | $109.90M | $111.10M |
| Total assets | $4.27B | $3.64B | $3.83B | $3.62B | $3.31B | $2.79B |
| Accounts payable | $253.70M | $239.30M | $242.40M | $215.40M | $232.20M | $213.10M |
| Total current liabilities | $654.90M | $550.40M | $671.80M | $519.00M | $594.10M | $503.40M |
| Long-term debt | $202.80M | $202.60M | $72.80M | $206.70M | $208.80M | $252.90M |
| Total liabilities | $1.09B | $961.10M | $948.50M | $931.90M | $978.40M | $939.30M |
| Retained earnings | $4.37B | $3.96B | $3.52B | $2.99B | $2.46B | $1.85B |
| Total equity | $3.18B | $2.68B | $2.88B | $2.68B | $2.34B | $1.85B |